-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Omada Health, Lowers Price Target to $30

Benzinga·03/06/2026 15:46:08
Listen to the news
Morgan Stanley analyst Craig Hettenbach maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $32 to $30.